- Report
- January 2026
- 189 Pages
Global
From €3445EUR$3,939USD£2,973GBP
- Report
- December 2025
- 200 Pages
Global
From €2615EUR$2,990USD£2,257GBP
- Report
- January 2026
- 185 Pages
Global
From €3445EUR$3,939USD£2,973GBP
- Report
- January 2026
- 196 Pages
Global
From €3445EUR$3,939USD£2,973GBP
- Report
- January 2026
- 185 Pages
Global
From €3445EUR$3,939USD£2,973GBP
- Report
- January 2026
- 188 Pages
Global
From €3445EUR$3,939USD£2,973GBP
- Report
- January 2026
Global
From €4286EUR$4,900USD£3,698GBP
- Report
- February 2026
- 384 Pages
Global
From €5117EUR$5,850USD£4,415GBP
- Report
- February 2026
- 268 Pages
Global
From €5117EUR$5,850USD£4,415GBP
- Report
- February 2026
- 140 Pages
Global
From €5117EUR$5,850USD£4,415GBP
- Report
- February 2026
- 387 Pages
Global
From €5117EUR$5,850USD£4,415GBP
- Report
- February 2026
- 180 Pages
Global
From €5117EUR$5,850USD£4,415GBP
- Report
- February 2026
- 413 Pages
Global
From €5117EUR$5,850USD£4,415GBP
- Report
- February 2026
- 196 Pages
Global
From €5117EUR$5,850USD£4,415GBP
- Report
- September 2025
- 250 Pages
Global
From €3927EUR$4,490USD£3,389GBP
- Report
- September 2025
- 250 Pages
Global
From €3927EUR$4,490USD£3,389GBP
- Report
- September 2025
- 250 Pages
Global
From €3927EUR$4,490USD£3,389GBP
- Report
- March 2025
- 200 Pages
Global
From €3927EUR$4,490USD£3,389GBP
- Report
- November 2025
- 200 Pages
Global
From €6954EUR$7,950USD£6,000GBP
- Report
- April 2025
- 200 Pages
Global
From €6954EUR$7,950USD£6,000GBP

Warfarin is a cardiovascular drug used to prevent and treat blood clots. It is an anticoagulant, meaning it helps to prevent the formation of clots in the blood vessels. Warfarin is used to treat and prevent deep vein thrombosis, pulmonary embolism, and atrial fibrillation. It is also used to reduce the risk of stroke in people with atrial fibrillation. Warfarin is available in both generic and brand-name forms.
The Warfarin market is highly competitive, with many companies offering generic and brand-name versions of the drug. Some of the major players in the market include Pfizer, GlaxoSmithKline, Sanofi, Bristol-Myers Squibb, and Merck. Other companies include Teva Pharmaceuticals, Mylan, and Novartis. Show Less Read more